EuropaBio Contribution to the Commission’s Public Consultation on Smart Regulation


EuropaBio Contribution to the  Commission’s Public Consultation on Smart Regulation 


1. Do you think that the Commission’s approach to improving existing legislation is appropriate, or do you believe there are more effective ways of doing so? Could you give us practical examples?
EuropaBio believes that Better Regulation is crucial for the biotech industry if Europe is to achieve the ambitious growth objectives set out in the EU Strategy for 2020. As an industry, we believe we must seize this opportunity to make the strategy a reality by creating supportive, facilitating regulation that encourages and stimulates responsible innovation to help people lead longer, healthier and greener lives. Biotechnology will play a key role in providing for the healthcare needs of our aging population whilst meeting market demands and reducing the impact on our environment. Better regulation will help to ensure that new technologies come to market in time to make a difference to today’s and tomorrow’s Europeans whilst reducing our carbon footprint and  mitigating the impacts of climate change. However, shaping future smart regulation will require decisive action and bold regulatory moves.  
EuropaBio strongly believes that the EU needs to lessen the regulatory burden on innovative industries. For example, the regulatory approval process in Europe has made European farmers less competitive globally. Around 50 GM products are awaiting approval in the EU, 18 of which are for cultivation. When European farmers are allowed access to GM crops, the 
evidence shows that they tend to choose to grow them.



Latest Position papers